The IRS recently released significant new guidance on the treatment of management contracts and other service contracts for property financed with tax-exempt bonds. This new guidance is, in some ways, much more flexible than prior guidance, but in some respects is stricter. Our webinar will focus on the new opportunities and challenges presented by the new guidance, including:
- Description of the new framework established by the rules
- New opportunities, particularly for longer-term contracts
- New requirements and challenges, particularly for shorter-term contracts
- Implementation of new tax compliance policies and approaches to respond to the new guidance
- Actions that should be considered prior to the end of the transition period
- Greater need for interpretation of safe harbors that provide fewer bright lines than prior guidance
There is no cost to participate in this program, but pre-registration is required. To participate, please use the Register Now button, or simply register here. Instructions for accessing the program will be included in the registration confirmation email.
If you have questions or would like more information, please contact Christina Wade at [email protected].
People
Related Insights
21 January 2025
Labor & Employment Law Perspectives
Trump Orders Hiring Freeze and Return to Work for Federal Employees
As part of the myriad executive orders issued by President Trump in the hours after his inauguration, two focus on the number and location of federal employees.
21 January 2025
Labor & Employment Law Perspectives
President Trump’s “Rescission” Executive Order
Among the executive orders issued by President Trump on January 20, 2025, was one titled Initial Rescissions of Harmful Executive Orders and Actions
21 January 2025
Health Care Law Today
DEA Unveils Long-Overdue Special Registration for Telemedicine in Proposed Rule
In the final days of the Biden administration, the DEA released a proposed rule that would allow practitioners with a Special Registration to prescribe Schedule III-V, and in limited circumstances Schedule II, controlled substances via telemedicine.